Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle

27th February 2026 Uncategorised 0

On some level, Eli Lilly’s partnership with computing giant Nvidia feels inevitable. The first pharma to reach a $1 trillion valuation teaming up with a tech firm that has ridden the AI wave to a record-setting $5 trillion valuation of its own—a Wall Street supergroup, a la Cream, Audioslave or boygenius.

More: Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
Source: fierce